FOXP3 + CD25-tumor cells with regulatory function in sézary syndrome

Journal of Investigative Dermatology

Volumn 129, Issue 12, 2009, Pages 2875-2885

  Heid, Julia B ^a   Schmidt, Angelika ^a   Oberle, Nina ^a   Goerdt, Sergij ^a   Krammer, Peter H ^a   Suri Payer, Elisabeth ^a   Klemke, Claus Detlev ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR MARKER;

ARTICLE; CELL CULTURE; CYTOLOGY; DNA METHYLATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MYCOSIS FUNGOIDES; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PROGNOSIS; PSORIASIS; REGULATORY T LYMPHOCYTE; SEZARY SYNDROME; SKIN; SKIN TUMOR; TUMOR EMBOLISM;

CELLS, CULTURED; DNA METHYLATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MYCOSIS FUNGOIDES; NEOPLASTIC CELLS, CIRCULATING; PHENOTYPE; PROGNOSIS; PSORIASIS; SEZARY SYNDROME; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TUMOR MARKERS, BIOLOGICAL;

EID: 79958106494     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.175     Document Type: Article

References (55)

1. Abe M, Uchihashi K, Kazuto T, Osaka A, Yanagihara K, Tsukasaki K et al. (2008) Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells. Eur J Haematol 81:209-17
2. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R et al. (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19:345-54
3. Banham AH, Brown PJ, Lyne L, Schulze HJ, Hallermann C (2008) Is FOXP3 expressed in cutaneous T-cell lymphomas? Eur J Haematol 80:90-1
4. Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J et al. (2007) DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37:2378-89
5. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20-1
6. Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N et al. (2005) Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105:1640-7
7. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA et al. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27:68-73
8. Bunn PA Jr, Lamberg SI (1979) Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep 63:725-8
9. Capriotti E, Vonderheid EC, Thoburn CJ, Wasik MA, Bahler DW, Hess AD (2008) Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma. Leuk Lymphoma 49:1190-201
10. Chen S, Ishii N, Ine S, Ikeda S, Fujimura T, Ndhlovu LC et al. (2006) Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int Immunol 18:269-77
11. Djemadji-Oudjiel N, Goerdt S, Kodelja V, Schmuth M, Orfanos CE (1996) Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis. Arch Dermatol Res 288:757-64
12. Ebert LM, Tan BS, Browning J, Svobodova S, Russell SE, Kirkpatrick N et al. (2008) The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 68:3001-9
13. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330-6
14. Fritzsching B, Oberle N, Eberhardt N, Quick S, Haas J, Wildemann B et al. (2005) In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand-but not to TCR-mediated cell death. J Immunol 175:32-6
15. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A et al. (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103:6659-64
16. Gjerdrum LM, Woetmann A, Odum N, Burton CM, Rossen K, Skovgaard GL et al. (2007) FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 21:2512-8
17. Gjerdrum LM, Woetmann A, Odum N, Hother C, Henrik-Nielsen R, Gniadecki R et al. (2008) FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations. Eur J Haematol 80:483-9
18. Grauer OM, Sutmuller RP, van MW, Jacobs JF, Bennink E, Toonen LW et al. (2008) Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model. Int J Cancer 122:1794-802
19. Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O (2008) FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 3:e1612
20. Jones D, Ibrahim S, Patel K, Luthra R, Duvic M, Medeiros LJ (2004) Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. Clin Cancer Res 10:5587-94
21. Karube K, Aoki R, Sugita Y, Yoshida S, Nomura Y, Shimizu K et al. (2008) The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma. Mod Pathol 21:617-25
22. Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Kawano R, Suzumiya J et al. (2004) Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br J Haematol 126: 81-4
23. Klemke CD, Brade J, Weckesser S, Sachse MM, Booken N, Neumaier M et al. (2008) The diagnosis of Sezary syndrome on peripheral blood by flow cytometry requires the use of multiple markers. Br J Dermatol 159: 871-80
24. Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N et al. (2006) Paucity of FOXP3(+) cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas. Leukemia 20:1123-9
25. Klemke CD, Mansmann U, Poenitz N, Dippel E, Goerdt S (2005) Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sezary syndrome. Br J Dermatol 153:118-24
26. Kohno T, Yamada Y, Akamatsu N, Kamihira S, Imaizumi Y, Tomonaga M et al. (2005) Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci 96:527-33
27. Kasprzycka M, Zhang Q, Witkiewicz A, Marzec M, Potoczek M, Liu X et al. (2008) Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes. J Immunol 181:2506-12
28. Krejsgaard T, Gjerdrum LM, Ralfkiaer E, Lauenborg B, Eriksen KW, Mathiesen AM et al. (2008) Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome. Leukemia 22:2230-9
29. Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D et al. (2005) Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 174:5968-76
30. Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA (2005) Expansion of functional endogenous antigen-specific CD4+ CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 175: 3053-9
31. Matsubara Y, Hori T, Morita R, Sakaguchi S, Uchiyama T (2005) Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells. Leukemia 19:482-3
32. Mittal S, Marshall NA, Duncan L, Culligan DJ, Barker RN, Vickers MA (2008) Local and systemic induction of CD4+CD25+ regulatory T cell population by non-Hodgkin's lymphoma. Blood 111:5359-70
33. Morice WG, Katzmann JA, Pittelkow MR, el-Azhary RA, Gibson LE, Hanson CA (2006) A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sezary syndrome. Am J Clin Pathol 125:364-74
34. Morice WG, Kimlinger T, Katzmann JA, Lust JA, Heimgartner PJ, Halling KC et al. (2004) Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques. Am J Clin Pathol 121:373-83
35. Oberle N, Eberhardt N, Falk CS, Krammer PH, Suri-Payer E (2007) Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J Immunol 179: 3578-87
36. Pillai V, Ortega SB, Wang CK, Karandikar NJ (2007) Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 123:18-29
37. Poenitz N, Dippel E, Klemke CD, Qadoumi M, Goerdt S (2003) Jessner's lymphocytic infiltration of the skin: a CD8+ polyclonal reactive skin condition. Dermatology 207:276-84
38. Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, Ling KL et al. (2005) Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level. Eur J Immunol 35:1681-91
39. Sakaguchi S, Powrie F (2007) Emerging challenges in regulatory T cell function and biology. Science 317:627-9
40. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-64
41. Sakaguchi S, Wing K, Miyara M (2007) Regulatory T cells-a brief history and perspective. Eur J Immunol 37Suppl 1:S116-23
42. Setoguchi R, Hori S, Takahashi T, Sakaguchi S (2005) Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201:723-35
43. Shimauchi T, Kabashima K, Tokura Y (2008) Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells. Cancer Sci 99:98-106
44. Talpur R, Jones DM, Alencar AJ, Apisarnthanarax N, Herne KL, Yang Y et al. (2006) CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma. J Invest Dermatol 126:575-83
45. Tiemessen MM, Mitchell TJ, Hendry L, Whittaker SJ, Taams LS, John S (2006) Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma. J Invest Dermatol 126: 2217-23
46. Tran DQ, Ramsey H, Shevach EM (2007) Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110:2983-90
47. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L et al. (2002) Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46:95-106
48. Waldmann TA, Greene WC, Sarin PS, Saxinger C, Blayney DW, Blattner WA et al. (1984) Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sezary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. J Clin Invest 73:1711-8
49. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH et al. (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J Clin Invest 112:1437-43
50. Walsh PT, Benoit BM, Wysocka M, Dalton NM, Turka LA, Rook AH (2006) A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection. J Invest Dermatol 126:690-2
51. Wan YY, Flavell RA (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci 102:5126-31
52. Wang HY, Wang RF (2007) Regulatory T cells and cancer. Curr Opin Immunol 19:217-23
53. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH et al. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105: 3768-85
54. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S et al. (2004) Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16:1643-56
55. Zheng Y, Manzotti CN, Burke F, Dussably L, Qureshi O, Walker LS et al. (2008) Acquisition of suppressive function by activated human CD4+ CD25-T cells is associated with the expression of CTLA-4 not FoxP3. J Immunol 181:1683-91